Avior Wealth Management’s Pulmonx LUNG Stock Holding History

Avior Wealth Management’s Portfolio LUNG Stock Details LUNG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-7	Closed	-$64	–	3089
2024 Q1	$64	Buy	+7	New	+$82	﹤0.01%	3385

Other funds holding LUNG

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Avior Wealth Management's LUNG Position: Q2 2024 in Review

Avior Wealth Management sold out of Pulmonx (LUNG) in Q2 2024, closing a stake of 7 shares — an estimated $64 sold.

Avior Wealth Management first reported a position in LUNG in Q1 2024 and held it in 1 quarter. The position peaked at $64 in Q1 2024. 111 funds tracked by Wall St. Rank hold LUNG as of Q2 2024.

Avior Wealth Management reported no remaining Pulmonx position as of Q2 2024 after selling out during the quarter.
Avior Wealth Management sold 7 Pulmonx shares in Q2 2024, an estimated $64.
Avior Wealth Management first reported a position in Pulmonx in Q1 2024 and held it in 1 quarter.
Avior Wealth Management's Pulmonx position peaked at $64 in Q1 2024.
111 funds tracked by Wall St. Rank held Pulmonx as of Q2 2024.

Based on Avior Wealth Management's 13F filing for Q2 2024, filed 13 Aug 2024.